Edap Tms SA
NASDAQ:EDAP

Watchlist Manager
Edap Tms SA Logo
Edap Tms SA
NASDAQ:EDAP
Watchlist
Price: 2.47 USD -0.8% Market Closed
Market Cap: 91.6m USD
Have any thoughts about
Edap Tms SA?
Write Note

Edap Tms SA
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Edap Tms SA
Capital Expenditures Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
Edap Tms SA
NASDAQ:EDAP
Capital Expenditures
-€490k
CAGR 3-Years
9%
CAGR 5-Years
-16%
CAGR 10-Years
-8%
Biomerieux SA
PAR:BIM
Capital Expenditures
-€338.2m
CAGR 3-Years
-5%
CAGR 5-Years
-7%
CAGR 10-Years
-10%
Carmat SA
PAR:ALCAR
Capital Expenditures
-€4.7m
CAGR 3-Years
-17%
CAGR 5-Years
-35%
CAGR 10-Years
-30%
Biosynex SA
PAR:ALBIO
Capital Expenditures
-€9.6m
CAGR 3-Years
13%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Visiomed Group SA
PAR:ALVMG
Capital Expenditures
-€2.6m
CAGR 3-Years
-120%
CAGR 5-Years
-28%
CAGR 10-Years
-23%
Amplitude Surgical SA
PAR:AMPLI
Capital Expenditures
-€18.9m
CAGR 3-Years
-26%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
No Stocks Found

Edap Tms SA
Glance View

Market Cap
91.2m USD
Industry
Health Care

EDAP TMS SA is a holding company, which through its subsidiary engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. The company is headquartered in Vaulx-En-Velin, Auvergne-Rhone-Alpes and currently employs 227 full-time employees. The firm operates worldwide via an extensive network of corporate offices, subsidiaries and distribution partners. The firm invests in Research & Development, partnering with INSERM French public laboratory and international medical research institutions. Company's activity is organized in two divisions: HIFU and UDS (including lithotripsy activities). The firm is developing HIFU technology (High Intensity Focused Ultrasound) in non-invasive treatment of prostate conditions with its range of Robotic HIFU devices, Ablatherm Fusion and Focal One. The firm is also developing ESWL (Extracorporeal ShockWave Lithotripsy) and Stone Laser that offers a range of minimally invasive solutions covering the full scope of urinary tract stone indications.

EDAP Intrinsic Value
7.06 USD
Undervaluation 65%
Intrinsic Value
Price

See Also

What is Edap Tms SA's Capital Expenditures?
Capital Expenditures
-490k EUR

Based on the financial report for Dec 31, 2023, Edap Tms SA's Capital Expenditures amounts to -490k EUR.

What is Edap Tms SA's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
-8%

Over the last year, the Capital Expenditures growth was 0%. The average annual Capital Expenditures growth rates for Edap Tms SA have been 9% over the past three years , -16% over the past five years , and -8% over the past ten years .

Back to Top